-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexaria Bioscience Enters Change Order To Terms Of Its Project Agreement With Novotech; Change Order Adds 5th Study Arm For Dehydratech-Tirzepatide Capsules In Its Australian Clinical Study; Change Order Results In Additional Costs Of AU$1.9M

Benzinga·06/12/2025 20:44:03
Listen to the news

-SEC Filing